Revvity Inc
RVTY: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|&j | LOCK|wG | LOCK|G# |
No-Moat Revvity Sees Solid First-Half Performance With Momentum Likely to Continue
Business Strategy and Outlook
Revvity, formerly PerkinElmer, has undergone a major transformation over the past decade. Following the 2023 divestiture of its applied, food, and enterprise services business, the firm rebranded as Revvity and now operates through two core segments, diagnostics and life sciences, with a strategic focus on enabling scientific breakthroughs and improving health outcomes.
